All

30 November 2017

Anaeropharma

Anaeropharma Science (Japan) pioneers the development of novel therapeutics based on its core platform technology, i-DPS, utilizing recombinant bifidobacterium. The technology...

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse